BioHarvest Sciences Inc.
BHST
$4.21
-$0.04-0.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.30% | 38.41% | -74.51% | 20.91% | -9.93% |
| Total Depreciation and Amortization | 12.47% | -5.41% | 2.01% | 17.01% | -2.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.06% | -57.04% | 274.05% | -17.19% | 0.33% |
| Change in Net Operating Assets | -98.96% | -323.91% | 3,018.18% | 102.90% | -1,479.17% |
| Cash from Operations | -7.70% | -43.61% | -2.03% | 40.27% | -35.82% |
| Capital Expenditure | -53.88% | 28.21% | 13.45% | -74.05% | 23.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 157.14% | -117.50% |
| Cash from Investing | -57.18% | 28.21% | 12.94% | -70.00% | 15.25% |
| Total Debt Issued | -51.49% | 63.55% | -20.97% | -2.17% | -- |
| Total Debt Repaid | -1,412.26% | -65.63% | -15.84% | 77.05% | -487.20% |
| Issuance of Common Stock | 229.83% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 53.48% | 308.05% | -23.57% | 27.22% | 1,596.34% |
| Foreign Exchange rate Adjustments | 89.47% | 258.33% | -200.00% | 90.70% | -760.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.58% | 2,120.55% | -67.75% | 367.46% | 84.25% |